These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2009-014876-23||A Phase 2 Study of EZN-2208 (PEG-SN38) administered with or without Cetuximab in patients with Metastatic Colorectal Carcinoma (mCRC)||2012-04-26||due-trials|